Clinical Trial Update: Pegylated Interferon Plus Ribavirin in the Treatment of Active and Past Intravenous Drug Users Infected With Hepatitis C [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating pegylated interferon plus ribavirin in active and past intravenous drug users with hepatitis C has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Pegylated interferon (pegylated interferon alfa)
• Ribavirin (ribavirin)

Snippet

Sponsor: University of Calgary | Conditions: Hepatitis c | Phase 4 | Status: COMPLETED